Nalaganje...

Ritonavir-Boosted Darunavir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Other Regimens for Initial Antiretroviral Therapy for People with HIV Infection: A Systematic Review

BACKGROUND: Darunavir is a second-generation protease-inhibitor used with ritonavir (DRV/r) and two nucleoside reverse-transcriptase inhibitors as an option in first-line antiretroviral treatment (ART). METHODS: We systematically reviewed randomized controlled trials (RCTs) of DRV/r versus other reg...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:AIDS Res Treat
Main Authors: Balayan, Tatevik, Horvath, Hacsi, Rutherford, George W.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5634582/
https://ncbi.nlm.nih.gov/pubmed/29082041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/2345617
Oznake: Označite
Brez oznak, prvi označite!